Efficacy of Calcium Dobesilate Versus Tranexamic Acid for Treating Heavy Menstrual Bleeding

NANot yet recruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

January 5, 2025

Primary Completion Date

November 5, 2025

Study Completion Date

December 31, 2025

Conditions
MenorrhagiaAbnormal Uterine Bleeding
Interventions
DRUG

Calcium dobesilate (Doxium)

This intervention is unique because Calcium Dobesilate is not a hormonal agent and does not carry the risks associated with hormonal therapies, such as potential impact on fertility or long-term endocrine effects. Additionally, it may be more suitable for patients who cannot tolerate hormonal treatments due to contraindications such as previous thrombotic events or risk factors for thrombosis.

DRUG

Tranexamic Acid

Tranexamic Acid stands out due to its non-hormonal action in managing menorrhagia, providing an alternative for women who are contraindicated for hormonal treatments or prefer non-hormonal solutions. Unlike other hormonal treatments, Tranexamic Acid does not impact fertility or have significant endocrine effects.

All Listed Sponsors
lead

University of Health Sciences Lahore

OTHER

NCT06763094 - Efficacy of Calcium Dobesilate Versus Tranexamic Acid for Treating Heavy Menstrual Bleeding | Biotech Hunter | Biotech Hunter